JourneyMeds resources
Physician-guided insights on peptide therapy, GLP-1 treatment, and medically supervised wellness.
Latest articles
The FDA's Pharmacy Compounding Advisory Committee is meeting July 23–24 to evaluate BPC-157, TB-500, and other peptides for legal compounding. Here's what it means for patients exploring physician-guided access.
BPC-157 can be accessed through a physician-guided telemedicine consultation and a licensed compounding pharmacy. Here's what the process actually looks like.
The BPC-157 and TB-500 combination — sometimes called the Wolverine Stack — pairs two peptides with complementary healing mechanisms. Here's what the evidence says and how to access it safely.
Semax and Selank are two peptide-based compounds studied for cognitive support, stress response, and anxiety reduction. They may be relevant for people exploring SSRI tapering.
If you've heard about GLP-1 medications like Ozempic or Wegovy, you've already encountered one class of peptides. Here's what the broader world of physician-guided peptide therapy looks like in 2026.
Medical content note: JourneyMeds articles are educational and do not replace individualized medical advice. Prescriptions, if appropriate, require review by a licensed clinician and may vary by state, pharmacy availability, and patient health history.